Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Mechanical Ventilation
NCT ID: NCT01967680
Last Updated: 2018-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
700 participants
INTERVENTIONAL
2014-01-31
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To assess the benefits and harms of non-sedation versus sedation with a daily wake-up trial in critically ill patients in ICU.
Design: The NONSEDA trial is an investigator-initiated, randomised, clinical, parallel-group, multinational, superiority trial designed to include 700 patients from at least six ICUs in Denmark, Norway and Sweden.
Inclusion criteria: Mechanically ventilated patients with expected duration of me-chanical ventilation \> 24 hours.
Exclusion criteria: non-intubated patients, patients with severe head trauma, coma at admission or status epilepticus, patients treated with therapeutic hypothermia, patients with PaO2/FiO2\<9 where sedation might be necessary to ensure sufficient oxygenation or place the patient in prone position.
Experimental intervention: Non-sedation supplemented with pain management during mechanical ventilation.
Control intervention: Sedation with a daily wake-up trial.
The primary hypothesis is that non-sedation compared to sedation and a daily wake-up trial will reduce mortality.
The secondary hypotheses are that non-sedation compared to sedation and a daily wake-up trial will:
* Reduce the incidence of a composite outcome of death, acute myocardial in-farction (AMI), stroke, pulmonary embolism and other thromboembolic events.
* Reduce the number of organ failures.
* Increase the days alive without mechanical ventilation.
* Increase the days alive outside the ICU.
* Increase the days alive outside the hospital.
Outcomes: The primary outcome is all-cause mortality at 90 days. Secondary out-comes are time to death in the trial period, the frequency of the trombo-embolic com-plications, acute renal failure, days alive without mechanical ventilation, days alive outside the ICU and hospital. Explorative outcomes are mortality at 28 days, organ failure and coma-free, delirium-free days.
Trial size: The investigators will include 700 participants (2 x 350) in order to detect or reject 25% relative risk reduction in mortality with a type I error risk of 5% and a type II error risk of 20% (power at 80%).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol.
NCT00675363
SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival
NCT04415060
Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome
NCT06014138
Sedation, ANalgesia and Delirium MANagement in Intensive Care Unit
NCT05027217
Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients
NCT01360346
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sedation with daily wake-up trial
The control group is sedated with continuous infusion to Ramsay score 3-4. During daytime, the patient is awakened as the intravenous infusion of sedatives is discontinued. After a successful wake-up, the infusion of sedative is resumed, starting on half of the pre-wake-up dose. If the patient becomes uncomfortable or agitated during the awakening, sedation is resumed, again starting with half the dosage. The infusion of sedatives is then adjusted to Ramsey score 3-4.
Controlgroup, sedation with daily wake-up trial
Non-sedation
This group will not receive sedatives. Patients are thoroughly and repeatedly informed by the staff of where they are, what have happened, and what type of treatment they are going to receive.
Participants in the non-sedated group are awake and have a natural sleep rhythm. In case these patients develop and outward delirium, it is necessary to have a nurse or other caregiver at the bedside in order to calm the patient. Patients with delirium are treated with haloperidol according to the U.S. guidelines, 2002 and the Danish national guidelines.
If, despite these measures, it is necessary to sedate an agitated patient more than twice, or where sedation might be necessary to ensure sufficient oxygenation or prone position, the patient is sedated and treated like the control-group. Every day during the wake-up trial it is evaluated whether the patient is able to continue the intervention of non-sedation.
Non-sedation for intubated, mechanically ventilated patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-sedation for intubated, mechanically ventilated patients
Controlgroup, sedation with daily wake-up trial
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Danish Medical Research Council
OTHER
Aase and Ejnar Danielsens Foundation
OTHER
Palle Toft
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Palle Toft
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Palle Toft, Professor
Role: STUDY_CHAIR
Odense University Hospital
Hanne Tanghus Olsen, MD
Role: PRINCIPAL_INVESTIGATOR
Svendborg Hospital
Helene K Nedergaard, MD
Role: PRINCIPAL_INVESTIGATOR
Kolding Sygehus
Thomas Stroem, Postdoc
Role: PRINCIPAL_INVESTIGATOR
Odense University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sydvestjysk Sygehus
Esbjerg, Region Syddanmark, Denmark
AArhus university Hospital, Noerrebrogade
Aarhus, , Denmark
Kolding Hospital
Kolding, , Denmark
Odense University Hospital
Odense, , Denmark
Svendborg Hospital
Svendborg, , Denmark
University Hospital of North Norway
Tromsø, , Norway
Vestfold Hospital
Tønsberg, , Norway
Linkjøbing University Hospital
Linköping, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Strom T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet. 2010 Feb 6;375(9713):475-80. doi: 10.1016/S0140-6736(09)62072-9. Epub 2010 Jan 29.
Oxlund J, Knudsen T, Strom T, Lauridsen JT, Jennum PJ, Toft P. Serum melatonin concentration in critically ill patients randomized to sedation or non-sedation. Ann Intensive Care. 2021 Mar 6;11(1):40. doi: 10.1186/s13613-021-00829-1.
Olsen HT, Nedergaard HK, Strom T, Oxlund J, Wian KA, Ytrebo LM, Kroken BA, Chew M, Korkmaz S, Lauridsen JT, Toft P. Nonsedation or Light Sedation in Critically Ill, Mechanically Ventilated Patients. N Engl J Med. 2020 Mar 19;382(12):1103-1111. doi: 10.1056/NEJMoa1906759. Epub 2020 Feb 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-20130025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.